申请人:Chemie Linz Aktiengesellschaft
公开号:US04778803A1
公开(公告)日:1988-10-18
The invention relates to new nitrogen-arylmethoxy-thiophene derivatives of the formula I ##STR1## wherein the R--CH.sub.2 --O-group is in position 4 or 5 of the thiophene ring, R denotes a 2-pyridinyl- or 2-quinolinyl group and R.sub.1 denotes a --COO-lower alkyl-, --CO--(CH.sub.2)n--CH.sub.3 or --CH(OH)--(CH.sub.2).sub.n --CH.sub.3 group, wherein n represents an integer from 2 to 6, and their hydrates and/or their pharmaceutically acceptable acid addition salts, a process for their preparation and pharmaceutical products containing these compounds. The new compounds and their salts have useful pharmacological properties. They can be used as active compounds for medicaments for the treatment and prevention of diseases, caused by a disturbance in arachidonic acid metabolism.
该发明涉及一种新的氮芳基甲氧基噻吩衍生物,其化学式为I,其中R--CH.sub.2--O基位于噻吩环的第4或第5位,R代表2-吡啶基或2-喹啉基,R.sub.1代表--COO-较低烷基-、--CO--(CH.sub.2)n--CH.sub.3或--CH(OH)--(CH.sub.2).sub.n--CH.sub.3基团,其中n表示2至6的整数,以及它们的水合物和/或它们的药学上可接受的酸盐,以及它们的制备方法和含有这些化合物的药物产品。这些新化合物及其盐具有有用的药理特性。它们可用作治疗和预防由花生四烯酸代谢紊乱引起的疾病的药物的活性成分。